Birgit Alsbjerg

ORCID: 0000-0002-7151-6245 · 11 papers in corpus
observational 2025
Scientific reports ·doi:10.1038/s41598-025-17793-6

Studies have suggested transferring Day 6 (D6) vitrified blastocyst in a frozen embryo transfer (FET) cycle. This study investigates whether D6 blastocysts should be transferred on the 5th or 6th day of progesterone administration during a …

rct 2025
Nature communications ·doi:10.1038/s41467-025-60205-6

The primary aim of the present randomised, double-blind, placebo-controlled trial was to investigate whether clindamycin and live Lactobacillus crispatus CTV-05 (LACTIN-V) would improve clinical pregnancy rates in IVF patients with abnormal…

observational 2025
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-025-03629-9

PURPOSE: To investigate baseline parameters and vaginal intimate hygiene habits comparing IVF patients with and without vaginal dysbiosis, a cross-sectional study. METHODS: Patients were grouped by the presence of vaginal dysbiosis status …

observational 2024
·doi:10.1093/humrep/deae108.664

Abstract Study question Does subcutaneous (SC) progesterone treatment provide progesterone levels comparable to intramuscular (IM) progesterone when using a cut-off level of 118nmol/l(37.1ng/ml) during intensive luteal phase support? Summar…

other 2024
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2023.103737

Endometriosis and adenomyosis are distinct clinical conditions that carry the same pathophysiological features. In recent years the clinical focus on assisted reproductive technology patients with either condition (E/A) has increased, in th…

other 2024
Human Reproduction ·doi:10.1093/humrep/deae202
nonrandomized-trial 2023
Human reproduction (Oxford, England) ·doi:10.1093/humrep/dead185

STUDY QUESTION: Can supplementation with rectal administration of progesterone secure high ongoing pregnancy rates (OPRs) in patients with low serum progesterone (P4) on the day of blastocyst transfer (ET)? SUMMARY ANSWER: Rectally adminis…

observational 2022
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2022.09.005

RESEARCH QUESTION: What is the optimal serum progesterone cut-off level in patients with endometriosis undergoing hormone replacement therapy frozen embryo transfer (HRT-FET) with intensive progesterone luteal phase support? DESIGN: A coho…

observational 2022
·doi:10.1093/humrep/deac107.285

Abstract Study question What is the optimal serum progesterone (P4) cut-off level for endometriosis patients undergoing hormone replacement therapy frozen embryo transfer (HRT-FET) with intensive exogenous progesterone luteal phase support?…

observational 2016
Drug design, development and therapy ·doi:10.2147/dddt.s104104

The first PIVET algorithm for individualized recombinant follicle stimulating hormone (rFSH) dosing in in vitro fertilization, reported in 2012, was based on age and antral follicle count grading with adjustments for anti-Müllerian hormone …

case-report 2008
Ugeskrift for laeger

We report a case in which a patient received IVF treatment due to massive pelvic endometriosis. The tubal patency and sperm parameters were normal. After e-SET (elective single embryo transfer) ultrasonography showed a triplet pregnancy wit…